Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria
AG181-C-002
Phase 1 other active
Quick answer
Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria for Phenylketonuria is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Phenylketonuria
- Phase
- Phase 1
- Modality
- other
- Status
- active